In addition, according to the analysis of corresponding genes expression and the TNM stage, we also found that the expression of CD39 and CD73 was higher in GC patients with clinic stage II, stage III, or stage IV than that in stage I, which revealed that these upregulated genes might be associated with tumor progression positively (Figure 3B). Here, NT5E is linked to gastric cancer.